AI in Pharmacovigilance: Prompting, Compliance, Workflows

Explore how pharmacovigilance evolved from manual processing to RPA and AI, pairing AI-assisted intake with human review to ensure compliant, audit-ready handling of unstructured data and case narratives.

Generative AI reshapes pharmacovigilance by enabling language-based interaction, offering structured first-draft outputs and knowledge support while demanding governance and responsible use.

Map AI across the four pharmacovigilance lifecycle quadrants: case intake, processing and assessment, regulatory reporting, and signal detection, to boost automation while preserving human control for causality and compliance.

In the AI era of pharmacovigilance, professionals must combine domain expertise with precise prompting, disciplined review, governance awareness, and cross-functional communication. These capabilities enable safer, more credible AI-assisted outcomes.

Map the AI landscape for pharmacovigilance by distinguishing AI, machine learning, NLP, and LLMs, and show how layered workflows, including classification, extraction, summarization, and retrieval, operate with governance.

Explore supervised, unsupervised, and transfer learning in pharmacovigilance, detailing how labeled decisions, patterns, and domain adaptation influence validation, interpretation, and task fit for safety teams.

Explore how AI drives classification, extraction, and summarization in pharmacovigilance to accelerate case intake, normalize unstructured sources, and support human review with audit trails.

Explore how retrieval augmented generation (RAG), small language models (SLMs), and agentic AI ground pharmacovigilance outputs in validated product labels, SOPs, and investigator brochures, enabling regulated, auditable workflows.

Explore how chatgpt, CLAWD, Gemini, and Copilot support regulated pharmacovigilance tasks like ICSR data extraction and narrative drafting while emphasizing data privacy, audit trails, and human review.

Explore GxP-compliant prompt engineering for PV tasks, applying zero-shot and few-shot methods to produce deterministic, structured JSON outputs, guiding data extraction and MedDRA coding with audit trails.

Engineer reliable prompts for regulated pharmacovigilance using a four-part framework: role, context, instruction, and constraint. Ensure outputs are deterministic, compliant, and audit-ready for ICSR, PSUR, and regulatory submissions.

Learn to spot common prompting errors in pharmacovigilance, such as vagueness, over-asking, weak source control, and over-trusting fluent outputs, and apply disciplined review and grounding to reduce risk.

Explore how AI enables case intake and triage in pharmacovigilance. Pre-populate structured fields and surface data quality flags for ICSR processing, with human oversight for regulatory compliance.

Draft chronology-first, source-grounded pharmacovigilance narratives with clear event evolution and exposure context. Standardize prompts and reviewer checks to ensure neutral wording, accuracy, and regulatory defensibility.

Explore how ai accelerates literature screening and signal support in pharmacovigilance by automating data ingestion, ai screening with disproportionality metrics, and end-to-end audit-trail driven human review.

Explore how generative AI enhances pharmacovigilance workflows—from document support to workflow orchestration and knowledge retrieval—while maintaining governance, traceability, and thorough review.

Adopt a GXP mindset to govern AI in pharmacovigilance, scaling controls to risk of outputs and defining intended use, inputs, and review steps. Map touchpoints, document evidence, and ensure defensibility.

Explore how to validate AI-enabled pharmacovigilance workflows by aligning with intended use, using realistic test data, defining acceptance criteria, and incorporating human review and post-implementation monitoring.

Document an auditable audit trail that explains how AI output is produced, reviewed, and approved. Retain source material and evidence to enable defensibility and inspector-ready traceability.

Define the intended use, document controls, and validation evidence to defend AI in pharmacovigilance before auditors. Outline review steps, access controls, and ongoing monitoring for a bounded, compliant workflow.

Learn how to manage data privacy and confidentiality in AI-driven pharmacovigilance workflows using practical habits like pre-prompt privacy checks, data minimization, de-identification, approved environments, and monitoring.

Explore how bias, hallucination, and reliability affect pharmacovigilance in AI-assisted workflows, and learn practical controls—prompt discipline, source visibility, and human review—to ensure trustworthy outputs.

Explore human-in-the-loop and human-on-the-loop governance for ai-assisted pharmacovigilance, detailing four-step workflows, seven oversight checks, and non-delegable safety sign-offs for regulatory compliance.

Promote ethical ai use in pharmacovigilance by protecting patients, preserving human judgment, and ensuring transparency, confidentiality, and fairness while surfacing uncertainty and avoiding hidden unfairness.

Explore how ai-enabled pharmacovigilance platforms aim to reduce manual effort across intake, triage, data extraction, coding support, and narrative drafting while preserving human review and accountability.

Evaluate major pharmacovigilance vendors using a five-lens framework: workflow coverage, quality and control features, usability for reviewers, AI feature maturity, and implementation realism.

PV teams ask structured vendor questions to assess AI tools for use case fit and control. They scrutinize data governance, post deployment reliability, audit trails, and correction workflows.

Evaluate build, buy, and hybrid AI strategies for pharmacovigilance, balancing speed, control, and governance to tailor a workflow that matches internal expertise and long-term maintainability.

Align AI use in pharmacovigilance with FDA and EMA guidance by prioritizing data quality, intended use, validation, documentation, and transparent human oversight that is explainable and governable.

Explore how the ema reflection paper shapes ai use in pharmacovigilance by prioritizing context, lifecycle monitoring, risk-based thinking, data quality, and transparent, human-involved processes.

Align AI governance across the medicine's lifecycle in pharmacovigilance, emphasizing lifecycle-aware governance, intended-use clarity, data provenance, change management, and cross-functional alignment to protect drug safety work.

Explore how SIAMS and industry thinking shape credible, safe AI adoption in pharmacovigilance, emphasizing governance, validated workflows, human ownership, and practical risk mitigation.

This lecture traces pharmacovigilance's ai progression from nlp and ml to generative and agentic systems, emphasizing governance, boundaries, and a practical checklist to align capabilities with risk and control maturity.

The future intelligent PV department blends human judgment with intelligent support layers for drafting, summarization, analytics, search, and structured decision support. Governance, training, and quality disciplines shape adoption and accountability.

Map and design a layered digital workforce with co-pilots, automation, analytics, and governance to route, summarize, and monitor cases while preserving human decision rights.

Learn why human judgment remains essential in pharmacovigilance for ambiguous cases, accountability, governance, and escalation, even as ai organizes facts and drafts options.